BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 28, 2003
View Archived Issues
Licofelone downregulates PMN/platelet function in vitro
Read More
Single-agent epratuzumab trial closes
Read More
RG-2133 enters phase I/II for bipolar disorder and major depression
Read More
Pharmacia claims new alpha7 nicotinic agonists for schizophrenia and cognitive dysfunction
Read More
AIDS vaccine developed at Emory and NIH enters clinical testing
Read More
Celera Genomics and Aventis jointly develop novel cathepsin S inhibitors
Read More
New integrin antagonists with utility in asthma covered by Aventis patent
Read More
Roche scientists prepare and test new 5-HT6 agonists
Read More
Lilly claims antitumor benzoylsulfonamides and sulfonylbenzamidines
Read More
Nippon Soda reports novel cGMP-PDE inhibitors with potential as vasodilators
Read More
Sato patent covers antibacterial quinolizinones
Read More
FR-167653 as a potential new therapy for endotoxemia
Read More
Further evidence supporting PARP inhibition as a therapeutic target in circulatory shock
Read More
Clinical testing of new PPARgamma agonist from Tularik commences
Read More
Rights to cantuzumab mertansine returned to ImmunoGen
Read More
HuMax-CD4 enters phase II clinical studies for CTCL
Read More
Clearance received in U.S. for efficacy trials of Helivax
Read More
Ketek deemed approvable by the FDA for respiratory tract infections
Read More
Abbott begins supplying Humira to pharmacies within a week of approval
Read More
Nastech reacquires rights to intranasal product for sexual dysfunction
Read More
BMS-207940: a second-generation ETA receptor antagonist with a favorable pharmacokinetic profile
Read More
CB1 receptor-mediated discriminative stimulus effects of Bay-38-7271
Read More
Naltrexone well tolerated and effective in pruritus caused by cholestasis
Read More
New data on once-daily lonafarnib in patients with advanced solid tumors
Read More
Improved bone mineral density found for teriparatide in male patients with osteoporosis
Read More